Ameritas Advisory Services’s Procept Biorobotics PRCT Stock Holding History

Ameritas Advisory Services’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361	Buy	+16	New	+$401	﹤0.01%	1861

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameritas Advisory Services's PRCT Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 16 shares worth $361. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings.

254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Ameritas Advisory Services held 16 shares of Procept Biorobotics worth $361 as of Q2 2026.
Procept Biorobotics was a new Ameritas Advisory Services position in Q2 2026.
Procept Biorobotics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1861 holding.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.